Prescriptions of Strong Opioid Analgesics in Primary Care (Pharmacy Care)
暂无分享,去创建一个
[1] N. Knezevic,et al. New Cancer Pain Treatment Options , 2017, Current Pain and Headache Reports.
[2] U. Hochberg,et al. Interventional Analgesic Management of Lung Cancer Pain , 2017, Front. Oncol..
[3] M. von Zastrow,et al. Molecular Pharmacology of δ-Opioid Receptors , 2016, Pharmacological Reviews.
[4] R. Chou,et al. CDC Guideline for Prescribing Opioids for Chronic Pain--United States, 2016. , 2016, JAMA.
[5] R. Al-Hasani,et al. Pain and Poppies: The Good, the Bad, and the Ugly of Opioid Analgesics , 2015, The Journal of Neuroscience.
[6] I. Andsoy,et al. Anxiety and pain in surgically treated breast cancer patients. , 2015, Asian Pacific journal of cancer prevention : APJCP.
[7] M. Etropolski,et al. Ready Conversion of Patients with Well-Controlled, Moderate to Severe, Chronic Malignant Tumor–related Pain on Other Opioids to Tapentadol Extended Release , 2014, Clinical Drug Investigation.
[8] T. Tzschentke,et al. The Mu-Opioid Receptor Agonist/Noradrenaline Reuptake Inhibition (MOR–NRI) Concept in Analgesia: The Case of Tapentadol , 2014, CNS Drugs.
[9] Marek Hakl. Zásady podávání analgetik , 2013 .
[10] Ondřej Sláma. Léčba průlomové bolesti u onkologických pacientů , 2013 .
[11] F. Roila,et al. Management of cancer pain: ESMO Clinical Practice Guidelines. , 2010, Annals of oncology : official journal of the European Society for Medical Oncology.
[12] A. Casy,et al. Opioid Analgesics , 1986, Springer US.
[13] S. Taillibert,et al. Neoplastic Meningitis Due to Lung, Breast, and Melanoma Metastases. , 2017, Cancer control : journal of the Moffitt Cancer Center.
[14] Marek Hakl,et al. Farmakoterapie léčby onkologické bolesti , 2007 .